Analyst defends ADXS’ new “astute” clinical development strategy to re-focus on leading product assets.
Analyst Swayampakula Ramakanth of H.C.
On November 9th, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) posted third-quarter financial earnings and held a conference call.
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) is dealing with the rejection from yesterday’s FDA Oncology Advisory Committee meeting for its pipeline drug Qapzola (apaziquone), designed …
In a research report released Friday, H.C.
H.C.
In a research report released today, H.C.
